• 제목/요약/키워드: bio-technology

검색결과 5,520건 처리시간 0.032초

청사 건물의 Bio-Attack에 따른 미생물 오염원 확산 및 제어방안에 관한 연구 (A Study on the Microbial Contaminant Transport and Control Method According to Government Building Bio- Attack)

  • 이현우;최상곤;홍진관
    • 설비공학논문집
    • /
    • 제20권4호
    • /
    • pp.252-259
    • /
    • 2008
  • The purpose of this study is to estimate the movement of microbial contaminant caused by bio-attack using bio-agent such as bacillus anthracis for preventing contaminant diffusion. multizone simulation was carried out in the case of three types of bio-attack scenario in the government building. Simulation results show that severe contaminant diffusion is brought about in all cases of bio-attack scenario in one hour, though pollution boundaries have different mode according to bio-attack scenarios. Simulation results also show that immune building technology such as filter and UVGI technology gives us powerful alternatives to meet the emergent situation caused by unexpected bio-attack.

Microfluidic Device for Bio Analytical Systems

  • Junhong Min;Kim, Joon-Ho;Kim, Sanghyo
    • Biotechnology and Bioprocess Engineering:BBE
    • /
    • 제9권2호
    • /
    • pp.100-106
    • /
    • 2004
  • Micro-fluidics is one of the major technologies used in developing micro-total analytical systems (${\mu}$-TAS), also known as “lab-on-a-chip”. With this technology, the analytical capabilities of room-size laboratories can be put on one small chip. In this paper, we will briefly introduce materials that can be used in micro-fluidic systems and a few modules (mixer, chamber, and sample prep. modules) for lab-on-a-chip to analyze biological samples. This is because a variety of fields have to be combined with micro-fluidic technologies in order to realize lab-on-a-chip.

Interpretation of Association Networks among Protein Sequence Motifs

  • Kam, Hye J.;Lee, Junehawk;Lee, Doheon;Lee, Kwang H.
    • Genomics & Informatics
    • /
    • 제1권2호
    • /
    • pp.75-79
    • /
    • 2003
  • Every protein can be characterized by either a distinct motif or a combination of motifs. Nevertheless, little is known about the relationships among (more than two) the motifs. Some of the proteins in the world are share motifs for evolutional or other biological benefits - they can save energy, time and resource for controlling and managing a variety of proteins. In some cases of motifs, the tendency is quite common and they can act the 'hub' motif of a network of the motif associations. The hubs are structurally and functionally important in themselves and also important in disease-related mutations. They will be highly resistant mutation to conserve their functions. But, in case of the a rare mutation, mutations on the position of hub can more easily cause fatal diseases.

Omics of Cancer

  • Bhati, Aniruddha;Garg, H.;Gupta, A.;Chhabra, H.;Kumari, A.;Patel, T.
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제13권9호
    • /
    • pp.4229-4233
    • /
    • 2012
  • With the advances in modern diagnostic expertise for cancer, certain approaches allowing scanning of the complete genome and the proteome are becoming very useful for researchers. These high throughput techniques have already proven power, over traditional detection methods, in differentiating disease sub-types and identifying specific genetic events during progression of cancer. This paper introduces major branches of omics-technology and their applications in the field of cancer. It also addresses current road blocks that need to be overcome and future possibilities of these methods in oncogenic detection.

Synthesis and Biological Activities of (4-Arylpiperazinyl)piperidines as Nonpeptide BACE 1 Inhibitors

  • Boja, Poojary;Won, Sun-Woo;Suh, Dong-Hoon;Chu, Jeong-Hyun;Park, Woo-Kyu;Lim, Hee-Jong
    • Bulletin of the Korean Chemical Society
    • /
    • 제32권4호
    • /
    • pp.1249-1252
    • /
    • 2011
  • Inhibition of BACE 1 activity is considered as a promising therapeutic target for Alzheimer's Disease (AD). Synthesis and inhibitory activities of (4-arylpiperazinyl)piperidines by bioisosteric replacement of a biaryl group with an arylpiperazine as BACE 1 inhibitors are described. The resulting (4-arylpiperazinyl)piperidines represent novel nonpeptide BACE 1 inhibitors with improved in vitro potency.